Catalyst Crew Technologies Corp. (OTC: CCTC) announced the development of NeuroAI, an artificial intelligence-enabled module designed to support neurological analysis and predictive risk modeling. The platform is intended to assist healthcare providers in analyzing neurological data and identifying potential clinical risks through AI-driven analytics, including early detection of neurological abnormalities, predictive modeling of cerebrovascular events, and AI-assisted analysis of brain imaging and cognitive data.
NeuroAI integrates multiple data inputs such as magnetic resonance imaging (MRI), electroencephalograms (EEG), cognitive assessments, and patient-specific data to generate structured outputs that support clinical review and care coordination. The platform is being developed as a specialized module within Catalyst Crew’s digital health ecosystem, which includes telehealth services, remote monitoring, and technology-enabled healthcare delivery environments.
The Company plans to integrate NeuroAI across its existing and planned healthcare infrastructure initiatives, including its healthcare services coordination platform, to support data-driven insights and clinical decision-support capabilities across neurological care pathways. Catalyst Crew Technologies intends to prioritize market development in Latin America, where AI-enabled healthcare technologies could help expand access to neurological evaluation tools, support early identification of conditions, and improve healthcare system efficiency.
Dr. Kevin Rodan Levy, Chief Executive Officer, stated: "Advancements in artificial intelligence present new opportunities to assist in the early identification and monitoring of neurological conditions. NeuroAI is part of our broader strategy to develop integrated, scalable healthcare technologies that can support medical professionals and improve patient care."
The Company intends to continue developing and refining NeuroAI while evaluating opportunities for pilot programs, strategic partnerships, and phased market deployment. For more information, visit https://catalystcrewai.com or review the Company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov.
Catalyst Crew Technologies is an AI-driven healthcare technology company focused on developing scalable digital health solutions for emerging markets, with an initial emphasis on Latin America. The Company is executing its strategic transition into AI-enabled healthcare and pursuing opportunities across telehealth infrastructure, remote patient monitoring, healthcare data analytics, and integrated digital care platforms.
